2022
State insurance mandates for in vitro fertilization are not associated with improving racial and ethnic disparities in utilization and treatment outcomes
Correia K, Kraschel K, Seifer D. State insurance mandates for in vitro fertilization are not associated with improving racial and ethnic disparities in utilization and treatment outcomes. American Journal Of Obstetrics And Gynecology 2022, 228: 313.e1-313.e8. PMID: 36356698, DOI: 10.1016/j.ajog.2022.10.043.Peer-Reviewed Original ResearchConceptsNon-Hispanic white womenClinical outcomesEthnic disparitiesFertilization cyclesFertility careAssisted Reproductive Technology Clinical Outcomes Reporting SystemBlack/African American womenWhite womenSingle stimulation cycleInsurance mandatesReproductive-aged womenRecent study yearsLack of insuranceAfrican American womenAutologous cyclesLiveborn neonatesCohort studyPrimary outcomeState insurance mandatesState health insurance mandatesStimulation cyclesTreatment outcomesWomenHealth insurance mandatesOutcomes
2013
Potential Mechanisms for Racial and Ethnic Differences in Antimüllerian Hormone and Ovarian Reserve
Tal R, Seifer DB. Potential Mechanisms for Racial and Ethnic Differences in Antimüllerian Hormone and Ovarian Reserve. International Journal Of Endocrinology 2013, 2013: 818912. PMID: 24348557, PMCID: PMC3857838, DOI: 10.1155/2013/818912.Peer-Reviewed Original ResearchOvarian reserveAntimüllerian hormoneRacial differencesSerum antimüllerian hormoneSerum AMH levelsVitamin D deficiencyReproductive technology treatmentEthnic differencesImportant clinical implicationsSuch racial differencesAMH levelsD deficiencyInfertility treatmentTreatment outcomesReproductive endocrinologistsReproductive planningEthnic groupsTimely interventionClinical implicationsReproductive agingSensitive biomarkerTechnology treatmentEthnic variationGenetic factorsPotential mechanisms
2012
Diagnosis and treatment of diminished ovarian reserve in assisted reproductive technology cycles of women up to age 40 years: the role of insurance mandates
Butts SF, Ratcliffe S, Dokras A, Seifer DB. Diagnosis and treatment of diminished ovarian reserve in assisted reproductive technology cycles of women up to age 40 years: the role of insurance mandates. Fertility And Sterility 2012, 99: 382-388.e7. PMID: 23102859, PMCID: PMC3561490, DOI: 10.1016/j.fertnstert.2012.09.026.Peer-Reviewed Original ResearchConceptsLive birth rateAge 40 yearsART cyclesART coverageElevated FSHOvarian reserveTreatment outcomesReproductive technology treatment outcomesSpecific infertility diagnosisState insurance coverageReproductive technology cyclesDiminished ovarian reserveProportion of cyclesCross-sectional studyBirth rateReporting System databaseInsurance mandatesMix of patientsProvider factorsInfertility diagnosisMAIN OUTCOMEFSHSignificant associationTreatment prognosisAdditional studies
1986
Critical reassessment of “second-look” exploratory laparotomy in epithelial ovarian cancer. II. Prognostic factors and treatment outcome in patients with persistent cancer
Miller D, Ballon S, Soriero O, Teng N, Seifer D. Critical reassessment of “second-look” exploratory laparotomy in epithelial ovarian cancer. II. Prognostic factors and treatment outcome in patients with persistent cancer. Gynecologic Oncology 1986, 23: 253-254. DOI: 10.1016/0090-8258(86)90256-8.Peer-Reviewed Original Research